Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Nasdaq Filing

<< Previous

Bullboard Posts

Next >>

Comment by PLITheOneon Nov 15, 2019 9:43am

41 Views

Post# 30355811

RE:RE:Nasdaq Filing

Indeed, this shelf prospectus is interesting.
Would like to know more about this!

GunnerG wrote: Whats that, shelf prospectus issuing more shares, whats that mean? DILUTION , just as I called it and nice they waited to get to the 52 week low, again, just as I called.

Wait for the big bounce. Meow meow

thewolf4 wrote:
Paperwork filed with the SEC to have the shares listed on the Nasdaq. The filing has an effective date of tomorrow after market close. The filing refers to the shelf prospectus filed a couple years ago so it seems the company is authorized to raise up to $250M CAD. Will be interesting to see how big the first raise is...